What is cognitive decline in the context of neuropsychology?
In neuropsychology, cognitive decline is defined as a reduction in one or more cognitive domains—including memory, attention, executive functions, language, perception, and social cognition—that exceeds what would be expected from normal aging and may affect daily functioning. According to guidelines from the American Psychological Association and international consensus criteria (NIA-AA and DSM-5), clinicians use standardized neuropsychological assessments, age- and education-adjusted normative data, and, when available, biomarkers to distinguish between expected age-related changes and pathological impairment.
Cognitive changes are generally considered clinically significant when performance falls approximately 1 to 1.5 standard deviations below the population mean and is associated with functional decline or progressive clinical symptoms. Deficits in planning, verbal memory, and inhibitory control are typically assessed through specialized neuropsychological batteries and interpreted within the broader context of daily functioning and longitudinal change.
Symptoms and signs of cognitive impairment
The signs and symptoms of cognitive impairment should be evaluated comprehensively and within the individual’s clinical context, following diagnostic criteria established by the American Psychiatric Association and recommendations from the American Academy of Family Physicians.
Common indicators of cognitive impairment include:
- Documented concern from the individual, a reliable informant, or a healthcare professional regarding a noticeable decline in cognitive functioning compared with previous levels.
- Objective deficits in one or more cognitive domains, including complex attention, executive function, learning and memory, language, visuospatial abilities, or social cognition, demonstrated through standardized neuropsychological testing.
- Functional impairment that interferes with independence in instrumental or basic activities of daily living, such as managing finances, medication, transportation, or personal care.
- Exclusion of alternative or reversible causes, including delirium, major depression, or other psychiatric and medical conditions, in accordance with DSM-5 guidelines from the American Psychiatric Association.
How to detect cognitive decline?
The detection of cognitive decline requires the use of standardized, validated, and sensitive neuropsychological assessments that are selected and adapted according to the patient’s cultural, linguistic, educational, and demographic characteristics. These tools allow clinicians to objectively evaluate different cognitive domains (memory, attention, language, executive functions, and visuospatial abilities) and compare results against appropriate normative data, facilitating the identification of changes from previous functioning and the distinction between normal aging and pathological processes.
Nesplora mild cognitive impairment tests
At Nesplora, we offer virtual reality-based attention tests that can be used to assess cognitive decline, such as the CPT tests, Nesplora Attention Adults Aquarium and Nesplora Attention Kids Aula. They are characterized by providing immersive environments that simulate functional situations of everyday life, increasing their ecological validity compared to traditional tests. These tools make it possible to accurately measure domains such as sustained attention, working memory, and inhibition, while recording performance and motor behavior variables in the presence of distractors. Their main advantages include:
- The ability to assess cognitive functions in an immersive environment.
- Improved motivation and engagement of the individual being assessed.
- The possibility of detecting subtle performance alterations that may anticipate future difficulties.
Proper use of cognitive tests to detect cognitive impairment
For the proper use of neuropsychological tests, it is recommended to:
- Select tests that are appropriate for the patient’s age, educational level, and sociocultural context.
- Compare results with up-to-date normative data.
- Consider emotional and environmental factors that may influence performance.
- Integrate findings with clinical observation and structured interviews.
These recommendations enable accurate interpretation and effective detection of cognitive alterations across different age groups.
Activities and treatment for cognitive decline
Activities for people with cognitive impairment are a fundamental component of non-pharmacological treatment and the prevention of cognitive decline. Scientific evidence supports multiple structured interventions that have demonstrated effectiveness in improving cognitive function and maintaining functional autonomy. Evidence-based recommended activities include:
- Structured cognitive stimulation targeting memory, calculation, language, and executive functions.
- Regular physical exercise — aerobic, resistance, or multicomponent — that promotes cardiovascular and brain health.
- Cognitive activities that challenge planning and decision-making.
- Combined interventions that simultaneously integrate physical exercise with cognitive components, and social activities that stimulate language and interpersonal interaction.
Personalizing these activities according to preserved abilities and individual interests is essential to maximize adherence and therapeutic benefits. Multidomain interventions that combine cognitive stimulation, physical exercise, social activities, and management of vascular risk factors have shown better results than single-component interventions. These activities promote neuroplasticity, the process through which the brain maintains its capacity for reorganization and adaptation, even in the presence of neurodegenerative disease.
References
- Climent, G. (2024). Viaje a tu cerebro: Factores clave y desafíos de la salud cognitiva en la mediana edad. Ediciones B.
- Gausemel, Å., Filkuková, P. (2025). Innovations in dementia screening: A systematic review and meta-analysis of virtual reality assessments. Frontiers in Psychology, 16, Article 1606562. https://doi.org/10.3389/fpsyg.2025.1606562
- Sabando, J., Centeno, P., Osorio, J., Rengel, M., & Ponce, J. (2023). Principales pruebas neuropsicológicas empleadas en el tamizaje del deterioro cognitivo en las personas mayores. Reincisol, 2(4), 338–359. https://doi.org/10.59282/reincisol.V2(4)338-359